Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation

被引:292
作者
Tammela, Tuomas
Saaristo, Anne
Holopainen, Tanja
Lyytikkae, Johannes
Kotronen, Anna
Pitkonen, Miia
Abo-Ramadan, Usama
Ylae-Herttuala, Seppo
Petrova, Tatiana V.
Alitalo, Kari
机构
[1] Univ Helsinki, Ludwig Inst Canc Res, Haartman Inst, Biomedicum,Mol Canc Biol Lab, FIN-00014 Helsinki, Finland
[2] Turku Univ, Cent Hosp, Dept Neurol, Expt MRI Lab, FIN-20521 Turku, Finland
[3] Univ Kuopio, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, FIN-70211 Kuopio, Finland
[4] Univ Helsinki, Biomedicum, Dev & Differentiat Lab, FIN-00014 Helsinki, Finland
关键词
D O I
10.1038/nm1689
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Surgery or radiation therapy of metastatic cancer often damages lymph nodes, leading to secondary lymphedema. Here we show, using a newly established mouse model, that collecting lymphatic vessels can be regenerated and fused to lymph node transplants after lymph node removal. Treatment of lymph node-excised mice with adenovirally delivered vascular endothelial growth factor-C (VEGF-C) or VEGF-D induced robust growth of the lymphatic capillaries, which gradually underwent intrinsic remodeling, differentiation and maturation into functional collecting lymphatic vessels, including the formation of uniform endothelial cell-cell junctions and intraluminal valves. The vessels also reacquired pericyte contacts, which downregulated lymphatic capillary markers during vessel maturation. Growth factor therapy improved the outcome of lymph node transplantation, including functional reconstitution of the immunological barrier against tumor metastasis. These results show that growth factor-induced maturation of lymphatic vessels is possible in adult mice and provide a basis for future therapy of lymphedema.
引用
收藏
页码:1458 / 1466
页数:9
相关论文
共 50 条
[31]  
Mortimer PS, 1996, QJM-MON J ASSOC PHYS, V89, P377
[32]   Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro [J].
Ng, CP ;
Helm, CLE ;
Swartz, MA .
MICROVASCULAR RESEARCH, 2004, 68 (03) :258-264
[33]   Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization [J].
Paik, JH ;
Skoura, A ;
Chae, SS ;
Cowan, AE ;
Han, DK ;
Proia, RL ;
Hla, T .
GENES & DEVELOPMENT, 2004, 18 (19) :2392-2403
[34]   Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis [J].
Petrova, TV ;
Karpanen, T ;
Norrmén, C ;
Mellor, R ;
Tamakoshi, T ;
Finegold, D ;
Ferrell, R ;
Kerjaschki, D ;
Mortimer, P ;
Yla-Herttuala, S ;
Miura, N ;
Alitalo, K .
NATURE MEDICINE, 2004, 10 (09) :974-981
[35]   VEGFR-1-selective VEGF homologue PlGF is arteriogenic -: Evidence for a monocyte-mediated mechanism [J].
Pipp, F ;
Heil, M ;
Issbrücker, K ;
Ziegelhoeffer, T ;
Martin, S ;
van den Heuvel, J ;
Weich, H ;
Fernandez, B ;
Golomb, G ;
Carmeliet, P ;
Schaper, W ;
Clauss, M .
CIRCULATION RESEARCH, 2003, 92 (04) :378-385
[36]  
RABSON JA, 1982, ANN SURG, V196, P92, DOI 10.1097/00000658-198207000-00019
[37]   VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses [J].
Rissanen, TT ;
Markkanen, JE ;
Gruchala, M ;
Heikura, T ;
Puranen, A ;
Kettunen, MI ;
Kholová, I ;
Kauppinen, RA ;
Achen, MG ;
Stacker, SA ;
Alitalo, K ;
Ylä-Herttuala, S .
CIRCULATION RESEARCH, 2003, 92 (10) :1098-1106
[38]   Lymphedema [J].
Rockson, SG .
AMERICAN JOURNAL OF MEDICINE, 2001, 110 (04) :288-295
[39]   Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds [J].
Saaristo, A ;
Tammela, T ;
Timonen, J ;
Yla-Herttuala, S ;
Tukiainen, E ;
Asko-Seljavaara, S ;
Alitalo, K .
FASEB JOURNAL, 2004, 18 (12) :1707-+
[40]   Lymphangiogenic gene therapy with minimal blood vascular side effects [J].
Saaristo, A ;
Veikkola, T ;
Tammela, T ;
Enholm, B ;
Karkkainen, MJ ;
Pajusola, K ;
Bueler, H ;
Ylä-Herttuala, S ;
Alitalo, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (06) :719-730